𝔖 Bobbio Scriptorium
✦   LIBER   ✦

S.19.05 Results of clinical trials of tiprolisant in narcolepsy and Parkinson's disease

✍ Scribed by I. Arnulf

Book ID
118595730
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
96 KB
Volume
19
Category
Article
ISSN
0924-977X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interpreting the results of Parkinson's
Interpreting the results of Parkinson's disease clinical trials: Time for a change
✍ Nick H. G. Holford; John G. Nutt πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 199 KB πŸ‘ 1 views

## Abstract Randomized clinical trials testing putative disease‐modifying agents in Parkinson's disease (PD) have yielded controversial results that have not influenced evidence‐based recommendations for the treatment of PD. We argue that the failure of these clinical trials may be linked to end po

Impact of placebo assignment in clinical
Impact of placebo assignment in clinical trials of Parkinson's disease
✍ Christopher G. Goetz; Kimberly Janko; Lucy Blasucci; Jean A. Jaglin πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 56 KB πŸ‘ 1 views

## Abstract Informed consent procedures in placebo‐controlled trials are developed to ensure that subjects entering studies clearly understand the possibility of placebo assignment. The extent of patient understanding and the impact of learning that they were assigned placebo treatment have not bee

[Handbook of Clinical Neurology] Parkins
[Handbook of Clinical Neurology] Parkinson's Disease and Related Disorders, Part II Volume 84 || Neuroprotection in Parkinson's disease: clinical trials
✍ STOCCHI, F πŸ“‚ Article πŸ“… 2007 πŸ› Elsevier 🌐 English βš– 197 KB

This volume provides comprehensive information on Parkinson’s disease and related disorders, a group of diseases that are among the most common in the field of neurodegenerative study. Through a high-level presentation of new research regarding these diseases, this handbook will give clinicians and